Clinical trial
Effect of Azimilide Dihydrochloride on Renal Function
NCT00318838 · Forest Laboratories, Industry · Completed
Key facts
| NCT number | NCT00318838 |
|---|---|
| Title | Effect of Azimilide Dihydrochloride on Renal Function |
| Official title | A Double-blind, Randomized, Parallel-group, Placebo-controlled, Multiple-dose Study to Assess the Effect of 125 mg/Day Orally Administered Azimilide Dihydrochloride on Renal Function and Hemodynamics in Healthy Volunteers |
| Lead sponsor | Forest Laboratories, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Azimilide dihydrochloride, Placebo |
| Enrollment | 21 |
| Start date | Apr 1, 2006 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Apr 27, 2006 |
| Last update posted | Feb 1, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: